AbbVie Inc. Payment for Contingent Consideration Liability, Operating Activities
Financial Statements › Cash Flow › Operating Activities
us-gaap:PaymentForContingentConsiderationLiabilityOperatingActivities · last filed 2026-08-03
- AbbVie Inc. payment for contingent consideration liability, operating activities for the quarter ending 2026-06-30 was $1.06B, a 23.63% increase year-over-year.
- AbbVie Inc. payment for contingent consideration liability, operating activities for the quarter ending 2026-03-31 was $722.00M, a 31.51% increase year-over-year.
- AbbVie Inc. payment for contingent consideration liability, operating activities for the quarter ending 2025-12-31 was $681.00M, a 26.35% increase year-over-year.
- AbbVie Inc. payment for contingent consideration liability, operating activities for the quarter ending 2025-09-30 was $776.00M, a 33.79% increase year-over-year.
- AbbVie Inc. payment for contingent consideration liability, operating activities for fiscal 2025 was $2.87B, a 43.61% increase from fiscal 2024.
- AbbVie Inc. payment for contingent consideration liability, operating activities for fiscal 2024 was $2.00B, a 129.31% increase from fiscal 2023.
- AbbVie Inc. payment for contingent consideration liability, operating activities for fiscal 2023 was $870.00M, a 430.49% increase from fiscal 2022.
- AbbVie Inc. payment for contingent consideration liability, operating activities for fiscal 2022 was $164.00M, a 80.22% increase from fiscal 2021.
| Period end | Payment for Contingent Consideration Liability, Operating Activities 3 month | Payment for Contingent Consideration Liability, Operating Activities 6 month | Payment for Contingent Consideration Liability, Operating Activities 9 month | Payment for Contingent Consideration Liability, Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.06B derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $1.78B 10-Q · filed 2026-08-03 | $2.46B derived: sum of 3 quarters · filed 2026-08-03 | $3.24B derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | $722.00M 10-Q · filed 2026-05-08 | $1.40B derived: sum of 2 quarters · filed 2026-05-08 | $2.18B derived: sum of 3 quarters · filed 2026-05-08 | $3.04B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | $681.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $1.46B derived: sum of 2 quarters · filed 2026-02-20 | $2.32B derived: sum of 3 quarters · filed 2026-08-03 | $2.87B 10-K · filed 2026-02-20 |
| 2025-09-30 | $776.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.64B derived: sum of 2 quarters · filed 2026-08-03 | $2.18B 10-Q · filed 2025-11-04 | $2.72B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | $859.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $1.41B 10-Q · filed 2026-08-03 | $1.95B derived: sum of 3 quarters · filed 2026-08-03 | $2.53B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $549.00M 10-Q · filed 2026-05-08 | $1.09B derived: sum of 2 quarters · filed 2026-05-08 | $1.67B derived: sum of 3 quarters · filed 2026-05-08 | $2.15B derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $539.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $1.12B derived: sum of 2 quarters · filed 2026-02-20 | $1.60B derived: sum of 3 quarters · filed 2026-02-20 | $2.00B 10-K · filed 2026-02-20 |
| 2024-09-30 | $580.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.06B derived: sum of 2 quarters · filed 2025-11-04 | $1.46B 10-Q · filed 2025-11-04 | $1.92B derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | $485.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $876.00M 10-Q · filed 2025-08-04 | $1.34B derived: sum of 3 quarters · filed 2026-02-20 | $1.73B derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $391.00M 10-Q · filed 2025-05-09 | $854.00M derived: sum of 2 quarters · filed 2026-02-20 | $1.25B derived: sum of 3 quarters · filed 2026-02-20 | $1.25B derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $463.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $854.00M derived: sum of 2 quarters · filed 2026-02-20 | $856.00M derived: sum of 3 quarters · filed 2026-02-20 | $870.00M 10-K · filed 2026-02-20 |
| 2023-09-30 | $391.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $393.00M derived: sum of 2 quarters · filed 2024-11-04 | $407.00M 10-Q · filed 2024-11-04 | $410.00M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $16.00M 10-Q · filed 2024-08-07 | $19.00M derived: sum of 3 quarters · filed 2025-02-14 | |
| 2023-03-31 | $14.00M 10-Q · filed 2024-05-03 | $17.00M derived: sum of 2 quarters · filed 2025-02-14 | ||
| 2022-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $164.00M 10-K · filed 2025-02-14 | ||
| 2022-09-30 | $161.00M 10-Q · filed 2023-11-06 | |||
| 2021-12-31 | $91.00M 10-K · filed 2024-02-20 |